MMP9 and ischemia: Specifically, it may be that the administration of CD147-blocking antibody before ischemia has a deleterious effect by suppressing the PC-induced facilitation of lactate release from astrocytes, whereas its administration after ischemia provides neuroprotection by inhibiting MMP-9 production.